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Abstract
Posttraumatic stress disorder (PTSD) occurs in 12-25% of survivors of acute life-threatening
medical events such as heart attack, stroke, and cancer, and is associated with recurrence of
cardiac events and mortality in heart attack survivors. This article reviews the current state of
knowledge about PTSD after such events, and proposes an Enduring Somatic Threat (EST) model
of PTSD due to acute life-threatening medical events to address underappreciated differences
between PTSD due to past, discrete/external traumatic events (such as combat) and PTSD due to
acute manifestations of chronic disease that are enduring/internal in nature (such as heart attack
and stroke). The differences include the external versus internal/somatic source of the threat, the
past versus present/future temporal focus of threatening cognitions, the different types and
consequences of avoidance behavior, and the different character and consequences of
hyperarousal. Although important differences between the two types of PTSD exist, the EST
model proposes that the underlying fear of mortality maintains PTSD symptoms due to both
discrete/external and ongoing/somatic events. Finally, this article offers a research agenda for
testing the EST model, with a particular focus on areas that may improve cardiovascular prognosis
and health behaviors in survivors of heart attack and stroke.
I have never been the same since. I suffer from extreme anxiety, hyper vigilance
and a host of other psychological symptoms related to my cardiac history. I am
hyper aware of every extra or missed heart beat which brings me right back to the
original arrhythmia. I struggle on a daily basis to do the most basic things.
Sophia, NYC, Comment in response to “Heart Attack Survivors May Develop
PTSD,” Tara Parker-Pope, New York Times, June 20, 2012.
Posttraumatic stress disorder (PTSD) is an anxiety disorder initiated by an exposure to a
discrete traumatic event that has generally occurred in the past, such as combat, disaster, or
sexual assault, and is characterized by symptoms such as re-experiencing (e.g., intrusive
thoughts, nightmares, flashbacks), cognitive or behavioral avoidance of reminders of the
event (e.g., avoiding thinking about the event, avoiding places or people associated with the
event), and physiological hyperarousal (e.g., difficulty sleeping, heightened startle reflex). It
is associated with abnormal amygdala, prefrontal cortex, and hippocampal function (Shin,
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Rauch, & Pitman, 2006) as well as abnormal neuroendocrinologic characteristics (Yehuda,
2006). In the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition; DSM-
IV) (American Psychiatric Association, 1994), life-threatening illness was recognized as an
event that can elicit PTSD, however, important differences between PTSD due to discrete
past events and PTSD due to ongoing medical illness have not been fully appreciated.
The potential for PTSD due to life-threatening illness has been studied most in cancer, acute
coronary syndrome (ACS; myocardial infarction or unstable angina), and increasingly,
stroke patients. While individual studies offer prevalence estimates for medically-induced
PTSD that vary widely, from 0% to more than 30%, large observational studies and meta-
analytic estimates within each literature have returned fairly consistent estimates of
approximately 12-25% (Edmondson & Cohen, 2013; Edmondson et al., 2012; Edmondson,
Richardson, et al., 2013). The implications of that estimate have not yet been appreciated by
patients, clinicians, or the health care system, and the popular conception of what PTSD is --
and who is at risk -- has lagged even farther behind.
Today in the U.S., there are 21 million veterans and about 1.5 million active duty service
people (United States Department of Defense, 2013). Only a proportion of those have seen
combat and are thereby vulnerable to combat-induced PTSD, though the nature of “combat”
exposure in the current conflicts is difficult to quantify. By comparison, according to the
American Heart Association, there are currently more than 17 million survivors of acute
manifestations of cardiovascular disease in the U.S. alone, with 1.2 million more added each
year, all of whom have survived a life-threatening acute medical event (Roger et al., 2012).
The health consequences of PTSD due to acute life threatening illness are substantial. In
survivors of cancer or stroke, the development of PTSD is associated with poorer physical
functioning, and mental and physical quality of life (Goldfinger et al., 2013; Shelby,
Golden-Kreutz, & Andersen, 2008). In acute coronary syndrome (i.e., myocardial infarction
or unstable angina) patients who develop PTSD due to the event, they are at double the risk
of ACS recurrence and mortality in the subsequent three years relative to their counterparts
who do not develop PTSD (Edmondson et al., 2012). A number of mechanisms likely
explain these associations, including sleep disruption (Shaffer, Kronish, Burg, Clemow, &
Edmondson, 2013), poor medication adherence (Kronish, Edmondson, Goldfinger, Fei, &
Horowitz, 2012; Shemesh et al., 2001), autonomic imbalance (Gander & von Kanel, 2006),
and increased systemic inflammation (von Kanel et al., 2010).
In all of the studies of PTSD due to a medical event or diagnosis, PTSD has been measured
using traditional PTSD screening instruments or clinical interviews keyed to a single event
in the past (i.e., the diagnosis and treatment of cancer or the experience of myocardial
infarction or stroke). However, a number of researchers have questioned whether PTSD due
to a medical event may have features that diverge conceptually and experientially from
traditional models of PTSD. For example, the re-experiencing symptoms of PTSD due to a
medical illness are often focused on enduring threats of recurrence and functional decline
rather than on a discrete event in the past whose danger has passed, and the avoidance,
negative alterations in cognition or mood, and hyperarousal symptoms may present in a
different manner and with different psychological, behavioral, and health consequences
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(Green et al., 1998). However, while the phenomenon currently (and perhaps rightly)
labeled PTSD due to acute medical illness does not fit neatly into the traditional PTSD
framework, it is also substantially distinct from other somatic fear-based phenomena such as
hypochondriasis or somatic anxiety—neither of which are rooted in an identifiable traumatic
trigger or have present a substantiated threat of mortality.
This article reviews the current state of knowledge about PTSD after such events, and
proposes an Enduring Somatic Threat (EST) model of PTSD due to acute life-threatening
medical events to address underappreciated differences between PTSD due to past, discrete/
external traumatic events (such as combat) and PTSD due to acute manifestations of chronic
disease that are chronic/somatic in nature (such as heart attack and stroke). The differences
include the external versus somatic source of the threat, the past versus present/future
temporal focus of threatening cognitions, the different types and consequences of avoidance
behavior, and the different character and consequences of hyperarousal. Although important
differences between the two types of PTSD exist, the EST model proposes that the
underlying fear of mortality maintains PTSD symptoms due to both discrete/external and
ongoing/somatic events. As can be seen in Table 1, a number of diagnostic criteria must be
met to be diagnosed with PTSD.
Scope
EST was developed to explain the maladaptive psychological and behavioral sequelae that
often follow life-threatening medical illnesses that are currently classified as symptoms or
correlates of PTSD. The most relevant phenomena are those psychological sequelae whose
features diverge from classical conceptions of PTSD symptoms or correlates, and those
behavioral sequelae with unique features or consequences in survivors of life-threatening
illness. Finally, EST proposes an underlying commonality that may give rise to both
classical presentations of PTSD and the unique presentation of PTSD-like sequelae of life-
threatening medical events.
Propositions
The following three propositions draw on quantitative and qualitative investigations of
medically-induced PTSD, and on existential social psychological and behavioral medicine
theories of PTSD and health behavior, including cognitive worldview models of PTSD
(Dalgleish, 2004), the Terror Management Health Model (Goldenberg & Arndt, 2008), and
Anxiety Buffer Disruption Theory (Edmondson, Chaudoir, et al., 2011; Pyszczynski &
Kesebir, 2011).
Proposition 1: Event Dimensions. There exist at least two distinctions between discrete/
external traumatic events and medical traumas. First, discrete/external traumas are
represented psychologically as having occurred in the past while medical traumas are
perceived as ongoing events of somatic origin that are recalled whenever attention is
directed toward the body. Second, discrete/external traumas are directed at the individual
from the outside while medical traumas reside within.
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Proposition 2: Character of Symptoms. PTSD symptoms due to medical events differ from
those due to discrete/external traumatic events due to their divergent temporal focus, the
nature and consequences of avoidance behaviors, and the relative necessity of vigilance to
signals of threat.
Proposition 3: Source of Distress. While the dimensions of the triggering event and the
character of PTSD symptoms differ between discrete/external trauma events and ongoing
medical traumas, the underlying source of distress for both is the terrifying awareness of
mortality that is made conscious by traumatic events of either type.
Proposition 1: The uniqueness of medical trauma as a triggering event
Life-threatening medical illness possesses all of the hallmarks of a potentially PTSD-
inducing event, but differs in important ways from discrete/external past traumatic events
(Smith, Redd, Peyser, & Vogl, 1999). The term life-threatening implies satisfaction of
Criterion A1, and though Criterion A2 (see Table) has been abandoned in DSM-V, research
has shown that many survivors report intense fear, helplessness, or horror (Palmer, Kagee,
Coyne, & DeMichele, 2004). Unlike the prototypical traumatic events such as combat or
sexual assault that have long been known to induce PTSD symptoms, however, medical
traumas are rarely discrete events with a defined endpoint. Once a discrete/external event
has concluded, the physical threat has usually subsided. Although a combat veteran who
experiences traumatic violence may thereafter develop a heightened awareness of the
possibility of non-combat violence in the world, she recognizes that the event that triggered
her PTSD symptoms is over, and that safe places exist wherein the threat of future violence
is exceedingly unlikely. In contrast, traumatic life-threatening illness is often the acute
manifestation of a permanently disrupted physiological system whose consequences may
last for years and place an ongoing threat squarely in the body of the survivor, from whence
no safe haven exists (Fox et al., 2006; Goldberg et al., 2004; Tang, Wong, & Herbison,
2007).
For example, the cancer experience often begins with suspicious test results, and continues
through cancer detection and diagnosis, and treatment that may be long-lasting, invasive,
and painful. Following the completion of active treatment and recovery, many patients must
continue to undergo regular oncologic check-ups for many years. Although cancer
recurrence rates vary, they are substantialfor many forms (Baker, Denniston, Smith, & West,
2005; Smith et al., 1999). Thus, the traumatic character of the cancer experience does not
reflect the horror of a discrete event, but rather arises from an often years-long experience of
vulnerability, pain, and fear. Further, the nature of the disease is such that continued
vigilance to threat is both statistically rational and prescribed by medical authorities.
Similarly, acute coronary syndromes and strokes are acute indicators of chronic disease that
recur with great frequency (Ay et al., 2010; Fox et al., 2006; Goldberg et al., 2004;
Jørgensen, Nakayama, Reith, Raaschou, & Olsen, 1997; Pedersen, van Domburg, & Larsen,
2004; Sacco, Wolf, Kannel, & McNamara, 1982; Tang et al., 2007), and require chronic
disease management and continued daily vigilance to physiological markers of
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cardiovascular functioning and life-long adherence to medication regimens (Redfern, Briffa,
Ellis, & Freedman, 2009; Smith Jr et al., 2011; Vedin et al., 2012).
ACS patients often report include intense fear (Bennett, Owen, Koutsakis, & Bisson, 2002),
perceived life threat, lack of control, (Doerfler, Paraskos, & Piniarski, 2005) helplessness
and chest pain during the ACS event (Wiedemar et al., 2008), and those factors are
associated with increased risk for PTSD, which is present in 1 out of every 8 ACS survivors
(Edmondson et al., 2012). These types of peri-traumatic factors (fear, perceived control,
pain) are also highly predictive of subsequent PTSD symptoms due to discrete/external
events. Although very few studies of medically-induced PTSD have assessed less traditional
perceptions of the medical event as an ongoing somatic threat, those that have done so find
that perceptions of a heart attack as central to the patient's identity, that the event is more
chronic than acute and has major consequences for the future, as well as negative emotional
representations of the illness are strongly predictive of subsequent PTSD symptoms
(Sheldrick, Tarrier, Berry, & Kincey, 2006). Such results suggest an important role for the
perception of an enduring somatic threat in medically-induced PTSD. Currently, little is
known about the long-term course or severity of PTSD due to cardiovascular events.
Wikman and colleagues(Wikman, Bhattacharyya, Perkins-Porras, & Steptoe, 2008) found
that 12% of 213 participants screened positive for ACS-induced PTSD at 12 months post-
ACS, and that 12.8% of 179 of those participants screened positive for ACS-induced PTSD
at 36 months. However, while PTSD symptoms were relatively stable, there were
participants who screened positive at 12 months who did not at 36 months, and vice versa,
as only 63% of the variance in 36 month PTSD symptoms were explained by 12 month
PTSD symptoms. In a different study with the longest follow-up to date, Ginzburg & Ein-
Dor found that half of those who developed PTSD initially still screened positive 8 years
later (Ginzburg & Ein-Dor, 2011). Thus, we require more information about the incidence,
prevalence, and course of PTSD symptoms due to acute, life-threatening medical illnesses to
understand if these symptoms are similar to, or diverge from the course taken by symptoms
due to more traditionally conceived traumas.
Stroke is among the most frightening of acute medical events, as it often results in sudden
and often progressive loss of bodily control and cognitive function. In one of the first
qualitative investigations of the subjective experience of stroke, stroke survivors interviewed
within 72 hours of stroke onset consistently described the terror of being awake and alert as
the affected arm and leg became weaker, often ending in complete paralysis of the entire
side of the body (Doolittle, 1991). The feelings most often cited in the acute phase were
shock, extreme fear, and desperation, and these feelings persisted throughout patients’
hospitalization, due to their uncertainty about continued loss of bodily control or recovery of
function over the first few days as the stroke evolved. Further, survivors described intense
disillusionment in learning that the hospital could not halt or reverse the damage caused by
the stroke, as the limits of technology and medical control became obvious. Finally, fear of
recurrence, impaired social functioning, and substantial physical disability contributed to
patients’ profound feelings of loss of control over the self and future. In another study that
followed patients over the 12 months following their stroke, patients described the fear of
dying that accompanied the stroke, as well as the inescapability of the stroke's bodily effects
and the near complete lack of control they experience months after the stroke (Burton,
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2000). These qualitative data suggest that the experience of a stroke is initially traumatic,
but that the lasting psychological damage is strongly associated with the ongoing
consequences of the event. Among stroke survivors screened within the first year after the
stroke, a recent meta-analysis suggests that as many as 1 in 4 screen positive for PTSD, and
among those screened after the first year, 1 in 8 screen positive (Edmondson, Richardson, et
al., 2013).
The desired outcome for most survivors of discrete/external, past, non-medical traumas is to
diminish the emotional tenor of the memory of the discrete traumatic event and relegate that
event to a distinct moment in the past. In contrast, after diagnosis of cancer or the experience
of an ACS or stroke, patients are required to make the occurrence of the event a primary
driver of many of their day to day activities. That is, they are asked to actively monitor and
combat an ongoing threat with lifestyle changes, medication regimens, and interactions with
the medical system—all of which are potent reminders of ongoing vulnerability, and of the
original trauma. Such reminders can be highly distressing (Whitaker, Watson, & Brewin,
2009), and have been associated with poor psychological adjustment in both cancer
survivors and cardiovascular disease patients (Edmondson, Park, Chaudoir, & Wortmann,
2008; Matsuoka et al., 2002).
Further, for discrete non-medical traumas, the trauma confronts the individual from the
outside, so that in its aftermath the individual can find havens of safety away from the
threatening context in which to recover and begin reintegrating into former life patterns.
However, for survivors of life-threatening illness, the source of the threat is within the body
itself, and as such is ever-present.
The temporal distinction between discrete events in the past and ongoing somatic threats has
led some researchers to question the conceptual fit of PTSD in medical populations (Anja
Mehnert & Koch, 2007; Mundy & Baum, 2004), as PTSD prevalence estimates in studies of
cancer patients are substantially lower when present- and future-oriented intrusive thoughts
or nightmares are not allowed to fulfill Criterion B (reexperiencing) (Green et al., 1998).
However, other research on the factor structure of responses to PTSD symptom inventories
has suggested that PTSD symptoms in medical populations tend to conform to DSM-IV
symptom clusters (Cordova, Studts, Hann, Jacobsen, & Andrykowski, 2000; DuHamel et al.,
2004). Since investigations of PTSD due to medical events began in earnest first in cancer
survivors and the traditional conceptualization of PTSD was generally accepted, subsequent
research in ACS and stroke patients has tended to ignore temporal distinctions in symptom
expression and treat medically-induced PTSD as if the medical trauma were a discrete past
event (Edmondson et al., 2012; Edmondson, Richardson, et al., 2013). The EST model
proposes a fundamental distinction between traumatic discrete/external events and ongoing/
somatic ones that may have important consequences for the identification of PTSD (or
PTSD-like disruptions) in survivors of acute life-threatening medical events. That distinction
may also have consequences for the character and consequences of PTSD symptoms after
acute life-threatening medical events.
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Proposition 2: Unique symptom features of medically-induced PTSD
PTSD can be usefully thought of as an overgeneralization of an intense fear response to a
conditioned stimulus, and a failure of fear extinction once the actual threat has subsided.
This model for understanding PTSD due to discrete/external, past events has proven highly
useful for developing successful psychotherapy approaches based on fear extinction
paradigms (eg., prolonged exposure). However, the fear extinction paradigm—at least for
exposure-based PTSD treatments-- is predicated on the notion that the threat itself has
passed, and that the diminished fear response to traumatic cues represents a match between
the true nature of the threat and the individual's cognitive orientation to it. That is, exposure-
based approaches seek to situate the traumatic event within a defined temporal-spatial
context that is removed from the individual's present context so that he or she can adopt a
more adaptive cognitive stance toward what is understood as a psychologically
uncomfortable but physiologically benign memory of the past.
In contrast, PTSD due to medical events represents an exaggerated and maladaptive fear
response to a valid and ongoing threat to an individual's existence. Whereas successful
extinction of the fear response to a past discrete/external event rightly places the threat of
mortality in the past so that the individual can resume a normative attitude toward death as
something that will occur somewhere in the distant future, modulation of the fear response
to an ongoing/somatic threat must acknowledge that the threat of mortality persists. Indeed,
the lifelong continued medical maintenance of secondary risk is prefaced on the fact that the
acute medical event signaled an ongoing vulnerability within the body itself that must be
monitored. This primary distinction between PTSD due to discrete/external, past events and
ongoing/somatic ones is apparent in the unique character of PTSD symptoms due to medical
events.
Reexperiencing symptoms
Diagnostic criteria for PTSD specify that re-experiencing symptoms are keyed to
“memories.” Since the vast majority of research on medically-induced PTSD has been
conducted from the traditional discrete traumatic event perspective, little is known about the
character of ongoing present and future-oriented “reexperiencing” symptoms such as
intrusive thoughts and nightmares. However, studies that have reported qualitative data on
present- and future-oriented symptoms suggest that the acute medical event (ie., cancer
diagnosis) is not cognitively distinct from ongoing concerns about present and future threats
implied by the event, even if assessed (?) years later (Matsuoka et al., 2002). Indeed, fear of
cancer progression, physical symptoms, doctors appointments, and other future-oriented
concerns have been shown to be strongly correlated with past-oriented intrusion symptoms
in breast cancer patients (A. Mehnert, Berg, Henrich, & Herschbach, 2009). In another
study, in which anxious cancer patients were asked to identify their most troubling intrusive
thoughts, 81% of intrusions reported were future oriented (e.g., I am going to die, the cancer
will not go away) (Whitaker et al., 2009). In our research, we have found that a substantial
proportion of cancer survivors (mean time since treatment end was 2 years) still think about
cancer at least once a day (47%) and many think about it multiple times a day (14%). In that
study, participants who thought most about cancer on a daily basis reported almost a full
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standard deviation worse mental health quality of life (SF-12 MCS) relative to those who
reported rarely thinking about it (Edmondson, Park, Blank, Fenster, & Mills, 2008; Park,
Edmondson, Fenster, & Blank, 2008).
Aside from the above distinctions between the character of re-experiencing symptoms due to
discrete/external past events versus that of re-experiencing symptoms due to acute life-
threatening events, there is some evidence that the consequences of re-experiencing
symptoms may themselves be differentially life-threatening for survivors of some types of
acute life-threatening medical events. In a study of 247 ACS patients, we found that 11%
screened positive for ACS-induced PTSD. Although screening positive for PTSD at 1 month
post-ACS was not itself a statistically significant independent risk factor for a recurrent ACS
event or mortality, participants who reported high re-experiencing symptoms were at more
than 3-fold increased risk for recurrent ACS or mortality in the 42 months after their index
ACS event (Edmondson, Rieckmann, et al., 2011).
This finding highlights the strong link between distressing psychological symptoms and the
activity of the cardiovascular system—which is driven largely by the autonomic nervous
system. Other research has found that intrusions are related to elevated systolic blood
pressure, blood markers of endothelial dysfunction (von Känel et al., 2008), and higher
circulating levels of both catecholamines (Hawk, Dougall, Ursano, & Baum, 2000) and C-
reactive protein (Miller, Sutherland, Hutchison, & Alexander, 2001), all of which are
important markers of cardiovascular risk that are more consequential for survivors of acute
cardiovascular events, at least in the near term, than for survivors of discrete/external past
events without cardiovascular disease.
Avoidance symptoms
The avoidance cluster of PTSD symptoms, like the other clusters, was observed first in
survivors of discrete/external traumatic events. In the case of combat veterans, survivors
may avoid thinking or talking about their combat experiences, may avoid loud noises or
outdoor environments that serve as reminders of the combat zone in which they served, or
avoid friends they made in the armed services. Although these strategies may not be
successful in keeping distressing thoughts at bay, and often represent a significant detriment
to quality of life, their continued use suggests that they provide negative reinforcement.
Symptoms of avoidance in patients with PTSD due to acute life-threatening illnesses that
indicate an ongoing somatic threat are more difficult to conceptualize. For survivors of heart
attack or stroke, how does a person avoid an awareness of an irregular heart beat or slightly
elevated blood pressure?
A year before DSM-IV made life-threatening illness a qualifying event for PTSD, Shalev
and colleagues described the phenomenon in 4 patients, and noted that PTSD was associated
with avoidance of future medical treatment (Shalev, Schreiber, Galai, & Melmed, 1993).
Since then, a growing number of studies have shown that PTSD symptoms are associated
with nonadherence to secondary prevention medications in both ACS (Shemesh et al., 2004)
and stroke survivors. For example, stroke survivors with PTSD symptoms suggestive of
likely PTSD diagnosis were almost 3 times as likely to be nonadherent to their prescribed
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medications as those without PTSD symptoms years after the index stroke event (Kronish et
al., 2012). Another study from that cohort of stroke survivors found that the association of
PTSD to nonadherence was mediated by increased concerns about medications (ie., they
disrupt my life, fear of side effects), but not their understanding of the necessity of those
medications for secondary prevention. That finding suggests that nonadherence to
medications may represent a deeper ambivalence created by conscious or unconscious
associations between medications and the event itself (Edmondson, Horowitz, Goldfinger,
Fei, & Kronish, 2013). EST posits that PTSD due to life-threatening medical events is
associated with nonadherence to medical treatment because such treatments serve as potent
reminders of the initial event and ongoing somatic threat represented by their chronic
disease.
Hyperarousal symptoms
Hypervigilance to threat cues, difficulty sleeping, and irritability are the prototypical
hyperarousal symptoms of PTSD, and are relatively common in survivors of discrete/
external traumatic events. However, little research has focused on hyperarousal symptoms in
medically-induced PTSD. Anecdotal data (see the opening quote of this article) suggest that
whereas hyperarousal symptoms due to discrete/external events are distressing physiological
responses to powerful memories, hyperarousal symptoms due to medically-induced traumas
are both focused on – and contributory to -- somatic cues of threat. PTSD due to ACS or
stroke is the best illustration of the unique character of hyperarousal symptoms in medically-
induced PTSD, because of the positive feedback loop between anxiety and sympathetic/
cardiovascular activity such as increased heart rate and blood pressure. When a heart attack
survivor is hypervigilant to cardiovascular indicators of threat, the anxiety caused by any
fluctuation in those highly variable indicators itself causes increased sympathetic and thus
cardiovascular activity.
Not only are the cardiovascular cues that may signal threat to a heart attack or stroke
survivor ubiquitous, but hyperarousal symptoms may actually influence future
cardiovascular risk. For example, research by von Kanel and colleagues have shown that
PTSD symptoms are associated with increased inflammation – an important risk factor for
cardiovascular events-- in survivors of myocardial infarction (von Kanel et al., 2010), likely
due to increased autonomic activity. Further, sleep difficulties associated with hyperarousal
in PTSD (Shaffer et al., 2013) may themselves be predictors of adverse cardiovascular
outcome in survivors of acute cardiovascular events (Cappuccio, Cooper, D'Elia, Strazzullo,
& Miller, 2011).
Proposition 3: Fear of death underlies both past and future oriented
symptoms
The defining characteristic of traumatic events is that they force a psychological
confrontation between an individual and mortality. Some cognitive/worldview models of
PTSD and social psychological theories such as terror management theory consider the fear
of mortality the primary driver of anxiety (Dalgleish, 2004). Such theories suggest that
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humans collectively rely on worldviews to assuage the fear of death, but that those
worldviews falter in the face of traumatic events (Janoff-Bulman, 1989).
For example, according to “shattered assumptions” theory (Janoff-Bulman, 1992),
individuals develop fundamental, yet unarticulated, assumptions about the world and
themselves (i.e., worldviews) that allow for healthy human functioning. The most important
assumptions include beliefs in a just, benevolent, predictable world in which the individual
possesses competence and worth. The worldview's primary function is to provide the
individual with meaning, self-esteem, and the illusion of invulnerability. Both worldview
models of PTSD and terror management theory (TMT) suggest that worldviews provide
people with a sense of meaning, structure, purpose, and invulnerability (Solomon et al.,
1991). The profound awareness of mortality that accompanies traumatic events has the
potential to incite psychological “terror” if individuals are unable to suppress thoughts about
their own inescapable mortality through redoubled investment in worldviews that promise
literal or symbolic immortality (Pyszczynski & Kesebir, 2011).
Anxiety buffer disruption theory combines two theoretical traditions (experimental
investigations of the cognitive and behavioral consequences of mortality awareness and
clinical investigations of PTSD), and has quickly accumulated support showing that
individuals with clinically significant PTSD symptoms are unable to suppress death-related
thoughts (Edmondson, Chaudoir, et al., 2011), and that the degree to which death-related
thoughts are cognitively accessible predict chronic PTSD symptoms. For example,
Abdollahi and colleagues showed that earthquake survivors with no PTSD symptoms
showed evidence of normal worldview defense (i.e., defending culturally important
components of worldview -- a marker of a functional, mortality-buffering worldview) after
reminders of mortality or reminders of the earthquake, while those with clinically significant
PTSD symptoms showed no such worldview defense (Abdollahi, Pyszczynski, Maxfield, &
Luszczynska, 2011). Most compelling, however, were the findings that the relationship
between initial psychological response to trauma and PTSD symptoms 2 years later was
partially mediated by decreased worldview defense (Abdollahi et al., 2011).
For all of these existential, worldview-based theories, traumatic events force survivors to
confront, with a newfound immediacy, the fact that their “self” and their body are one and
the same. While the destruction of intuitive dualism, and the awareness of mortality that
accompanies it, are problematic for many trauma survivors, those who survive acute life-
threatening medical events that imply enduring somatic threat are particularly vulnerable. In
documenting his death from cancer in the memoir Mortality, Christopher Hitchens sums up
the conflict.
Always prided myself on my reasoning faculty and my stoic materialism. I don't
have a body, I am a body. Yet consciously and regularly acted as if this was not
true, or as if an exception would be made in my case.
Particularly for medically-induced PTSD, difficulty suppressing awareness of the ongoing
threat of mortality that exists in the body may be heightened by hypervigilance toward
somatic threat cues. An important line of research for understanding the association between
somatic focus and awareness of mortality has emerged in recent years, and has shown that
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reminders of the body's corporeality induce death-related thoughts and profound
psychological reactions (Cox, Goldenberg, Pyszczynski, & Weise, 2007). In one of the most
striking studies to illuminate the link between a focus on the body and mortality concerns, a
means for understanding the ironic association between PTSD and nonadherence to
medication in ACS and stroke survivors can be found. Goldenberg and colleagues showed
that after mortality was made salient for women participants, reminders of their body's
fallible nature reduced intentions to conduct breast self-examinations (BSE). In a second
study, they found that conducting BSEs increased death-thought accessibility, and reminders
of the body's fallible nature decreased the time women spent conducting BSEs (Goldenberg,
Arndt, Hart, & Routledge, 2008). Similarly, for women high on neuroticism reminders of
mortality and the fallibility of the body caused increased desire to avoid thinking about
mammography, and in a second study, caused increased discomfort during a mammography
(Goldenberg, Routledge, & Arndt, 2009). Observations that mortality awareness may have
ironic effects on health behaviors led to the development of the terror management health
model (TMHM), which lays out the conditions under which psychological confrontations
with the physical body can undermine symbolic defenses against mortality and, ironically,
serve as barriers to health promotion behaviors (Goldenberg & Arndt, 2008).
Future Directions
EST can inform unique physiological and behavioral challenges associated with
psychological and medical management of patients with PTSD due to life-threatening
illness. Although there are a number of personality (e.g., neuroticism), psychological (e.g.,
prior anxiety or mood disorder), demographic, and social or situational factors (family
conflict, job or work related issues or losses) that may predispose survivors of acute medical
events to develop PTSD, those factors are also predictors of PTSD due to discrete/external
traumatic events, and thus do not appear to offer unique insight into medically-induced
PTSD. EST predicts that the degree of life-threat subjectively experienced by the individual
at the acute onset of the traumatic medical event is the most powerful prognostic factor for
later PTSD. Second, the medical prognosis associated with the event will help to determine
the severity and duration of PTSD symptoms. Third, more frequent experiences of somatic
symptoms that can serve as reminders of impending mortality and will predict the
frequency, severity, and duration of PTSD symptoms. Fourth, patients with PTSD will
experience increased awareness of -- and physiological reactivity to --somatic indicators of
disease, will attempt to avoid reminders of mortality through cognitive or behavioral
attempts to disengage from the body (e.g., distraction, substance use), will avoid medical
treatments associated with the event, and will be at greater risk for recurrence of acute
exacerbations of disease (e.g., recurrent ACS). As such, the previously observed
associations between medically-induced PTSD and medication non-adherence can be
explained by explicit or implicit aversive associations between secondary prevention
medications and the traumatic event, and ironically, with mortality.
A research agenda based on the EST model should first test whether the proposed
uniqueness of trauma due to medical events, relative to discrete past traumatic events, is
confirmed by patient experience using both qualitative and quantitative research methods.
Second, it should further illuminate important differences in PTSD onset, symptom
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character, risk and maintaining factors, and chronicity between PTSD caused by ongoing/
somatic and discrete/external past events. In particular, the influence of the enduring
character and somatic source of the traumatic threat should be investigated. Similarly,
research should disentangle the dual influences of the ongoing nature and somatic source on
the presentation of PTSD symptoms, perhaps by comparing PTSD symptom reports of
medical patients with survivors of motor vehicle accidents, for whom a threat of
“recurrence” is also ongoing. Third, a thorough investigation of the role of mortality fears in
the initiation, maintenance, and symptom expression should be conducted, with particular
emphasis on the role of heightened somatic vigilance in the disruption of normative fear
extinction in survivors of life-threatening illness.
Conclusions
Across a number of different acute life-threatening medical events, recent meta-analyses
suggest that 12-25% of survivors develop significant PTSD symptoms (Edmondson &
Cohen, 2013; Edmondson et al., 2012; Edmondson, Richardson, et al., 2013). Given the
frequency with which these events occur, medically-induced PTSD thus represents the lion's
share of the PTSD burden in most developed countries. Based on these estimates, as many
as 168,000 ACS patients and more than 200,000 stroke survivors will develop clinically
significant symptoms of PTSD this year in the U.S. alone. It is important to note that, unlike
PTSD due to many discrete/external traumatic events, PTSD due to acute life-threatening
medical events develops at least in part while patients are in our hospitals. The way that we
structure those hospitals and deliver care should take into account that those factors may
contribute to patients’ PTSD symptoms in the future (Edmondson, Shimbo, Ye, Wyer, &
Davidson, 2013). Aside from the obvious mental health and quality of life consequences of
the disorder, cardiovascular disease patients who develop PTSD also experience increased
cardiovascular risk. For example, as mentioned above, ACS-induced PTSD has been
associated with a doubling of risk of recurrence and mortality (Edmondson et al., 2012), and
stroke-induced PTSD has been associated with behavioral risk factors such as nonadherence
to medications (Kronish et al., 2012).
To date, PTSD symptoms due to acute medical events have been assessed with measures
designed to assess PTSD due to a discrete past event that occurred outside the individual,
rather than an enduring somatic threat of mortality. That strategy overlooks important
distinctions between the two phenomena, and fails to identify potentially important avenues
for intervention and medical management of patients at increased medical and psychological
risk. By acknowledging the unique qualities of medically-induced PTSD, researchers and
clinicians can open new avenues for understanding and treating this highly prevalent but
largely overlooked response to common life-threatening illnesses.
A recent systematic review and meta-analysis (Nenova et al., 2013) suggested that 68% of
the 19 randomized controlled trials (RCTs) so far tested for reduction of PTSD symptoms in
cancer survivors showed no effect, and only 1 study showed a consistent reduction across all
PTSD symptom clusters. To date, only one pilot RCT of cognitive behavioral therapy for
PTSD due to cardiovascular disease has been conducted, which was powered only to assess
safety of the approach in cardiac patients (Shemesh et al., 2011). If the research agenda laid
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out by the EST model uncovers the expected associations between medical symptoms,
somatic focus, and enduring mortality fears, clinicians should look for ways to modify
existing PTSD treatments in order to acknowledge the actual ongoing somatic threat
experienced by survivors, address the present- and future-focus of medically-induced PTSD
symptoms, discuss the meaning of and appropriate response to somatic symptoms, and be
aware of avoidance strategies that patients might employ to reduce psychological discomfort
but that may ironically increase their recurrence and mortality risk.
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DSM-V Diagnostic Criteria for PTSD
Criteria
A. Stressor The person was exposed to:
death, threatened death, actual or
threatened serious injury, or




3.Indirectly, by learning that a close relative or close friend was exposed
to trauma. If the event involved actual or threatened death, it must have
been violent or accidental.
4.Repeated or extreme indirect exposure to aversive details of the
event(s), usually in the course of professional duties (e.g., first
responders, collecting body parts; professionals repeatedly exposed to
details of child abuse). This does not include indirect non-professional
exposure through electronic media, television, movies, or pictures.
B. Intrusion symptoms The traumatic event is
persistently re-experienced: (1
required)
1. Recurrent, involuntary, and intrusive memories. Note: Children older
than 6 may express this symptom in repetitive play.
2.Traumatic nightmares. Note: Children may have frightening dreams
without content related to the trauma(s).
3.Dissociative reactions (e.g., flashbacks) which may occur on a
continuum from brief episodes to complete loss of consciousness. Note:
Children may reenact the event in play.
4.Intense or prolonged distress after exposure to traumatic reminders.
5.Marked physiologic reactivity after exposure to trauma-related
stimuli.
C. Avoidance Persistent effortful avoidance of
distressing trauma-related stimuli
after the event: (1 required)
1.Trauma-related thoughts or feelings.
2.Trauma-related external reminders (e.g., people, places, conversations,
activities, objects, or situations).
D. Negative alterations in
cognitions and mood
Negative alterations in cognitions
and mood that began or worsened
after the traumatic event: (2
required)
1. Inability to recall key features of the traumatic event (usually
dissociative amnesia; not due to head injury, alcohol or drugs).
2.Persistent (and often distorted) negative beliefs and expectations about
oneself or the world (e.g., “I am bad,” “The world is completely
dangerous.”).
3.Persistent distorted blame of self or others for causing the traumatic
event or for resulting consequences.
4.Persistent negative trauma-related emotions (e.g., fear, horror, anger,
guilt or shame).
5.Markedly diminished interest in (pre-traumatic) significant activities.
6.Feeling alienated from others (e.g., detachment or estrangement).
7.Constricted affect: persistent inability to experience positive emotions.
E. Alterations in arousal and
reactivity
Trauma-related alterations in
arousal and reactivity that began
or worsened after the traumatic
event: (2 required)
1. Irritable or aggressive behavior.





F. Duration Persistence of symptoms (in
Criteria B, C, D and E) for more
than one month.
G. Functional significance Significant symptom-related
distress or functional impairment
(e.g., social, occupational).
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